BRCA2 Ag:PrThr:Pt:Tiss:Ord:Immune stain

Known as: BRCA2 Ag:PrThr:Moment:Weefsel en uitstrijkjes:Ordinaal:Immunokleuring, BRCA2 antigène [Arbitraire/Volume] Tissu ; Qualitatif ; Coloration immune, BRCA2 ??:PrThr:??????:??:???:????????????????????? ??????? 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
PURPOSE To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is associated with reduced contralateral breast… (More)
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE To compare breast cancer prognosis in BRCA1 and BRCA2 mutation carriers with that in patients with sporadic disease… (More)
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2011
2011
Several common alleles have been shown to be associated with breast and/or ovarian cancer risk for BRCA1 and BRCA2 mutation… (More)
  • table 1
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Genome-wide association studies of breast cancer have identified multiple single nucleotide polymorphisms (SNPs) that are… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Germline mutations in BRCA1 and BRCA2 confer high risks of breast cancer. However, evidence suggests that these risks are… (More)
Is this relevant?
2006
2006
BACKGROUND Screening mammography is associated with a small dose of radiation to the breast, and women with increased genetic… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Women with a BRCA1 or BRCA2 mutation have a high risk of breast cancer and may choose to undergo prophylactic… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
H ANNE M EIJERS -H EIJBOER , M.D., B ERT VAN G EEL , M.D., P H .D., W IM L.J. VAN P UTTEN , M.S C ., S ONJA C. H ENZEN -L OGMANS… (More)
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Women with a mutation in BRCA1 or BRCA2 have a high risk of developing breast cancer and of contralateral cancer after… (More)
Is this relevant?